Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
NCT00267488
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Endometrial
Endometrial Cancer
Interventions
DRUG:
topotecan
Sponsor
GlaxoSmithKline